Stocktoria

Nkarta, Inc. NKTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-07-10

Nkarta, Inc. statistics & valuation

Market cap$202.5M
P / B0.6×
Return on equity-33.3%
Return on capital-31.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-19433.90% 2019202020212022202320242025
Return on equity (%)
-28.40% -34.30% -30.60% -43.00% -26.70% -33.30% 2019202020212022202320242025
Shares outstanding
1.6M 32.6M 33.0M 48.9M 49.2M 70.6M 74.0M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-43.50% -27.10% -31.40% -24.10% -31.00% -21.70% -25.80% 2019202020212022202320242025
Free cash flow margin (%)
-17647.80% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$2.62 -$2.61 -$2.40 -$1.60 -$1.41 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin——————-19433.9%
Net margin——————-18327.0%
FCF margin——————-17647.8%
Return on assets-25.8%-21.7%-31.0%-24.1%-31.4%-27.1%-43.5%
Return on equity-33.3%-26.7%-43.0%-30.6%-34.3%-28.4%82.7%
Current ratio12.6914.4510.8516.3618.9936.104.59

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.